Skip to content
CompanySight
Company No. 04045527 · Incorporated 28 Jul 2000

Orchid Cellmark Ltd

Registered name: ORCHID CELLMARK LTD

Part of Eurofins Scientific S.E. group

Orchid Cellmark Ltd made £33.1m revenue and a £6.6m loss in the year to 31 Dec 2024.

Orchid Cellmark Ltd’s revenue grew 4% to £33.1m in the year to 31 Dec 2024, with a loss of £6.6m and 542 employees. The company is classified under “technical testing and analysis” and is based in Wolverhampton; we hold 4 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 71200Technical testing and analysis
Status
Active
Location
Wolverhampton, West Midlands
Age
26 yrs · since 2000
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “DNACO Limited”

Latest accounts · year to 31 Dec 2024

Key figures

Capital-lightDoing more with less
Revenue
£33.1m
Growth ▲4%
Profit
−£6.6m
Growth —
Profit margin
−20%
Gross 74.5%
Employees
542
Change ▼2.2%
Profit / employee
−£12.2k
Revenue/employee £61.1k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202131 Dec 202231 Dec 202331 Dec 2024
DisclosureFull P&LFull P&LFull P&LFull P&L
Profit & loss
Revenue (turnover)£30.1m£28.2m£31.8m£33.1m
Cost of sales£24.9m£27.1m£26.8m£8.4m
Gross profit£5.2m£1.1m£5m£24.7m
Profit before tax−£794k−£6m−£2.5m−£6.6m
Profit after tax−£1.1m−£6.5m−£2.5m−£6.6m
Profit (best available)−£1.1m−£6.5m−£2.5m−£6.6m
Staff costs£19m£20.9m£21.3m£22.6m
Employees (average)528539554542
Ratios
Profit margin−3.7%−23%−7.9%−20%
Gross margin17.3%4%15.7%74.5%
Revenue per employee£57k£52.3k£57.4k£61.1k
Profit per employee−£2.1k−£12k−£4.5k−£12.2k
Growth (year on year)
Revenue growth—▼6.4%▲12.9%▲4%
Headcount growth—▲2.1%▲2.8%▼2.2%
Balance sheet — indirect signals, not revenue
Cash at bank£1.1m£157k£157k£335k
Net assets£6.1m−£354k−£2.9m−£5.9m
Fixed assets£976k£1.6m£1.5m£666k
Current assets£9.9m£5.9m£5.2m£9.6m
Debtors£4m£3.1m£2.1m£3.7m
SourceAccounts · bulk data May 2024Accounts · bulk data May 2024FullAccounts · bulk data Jan 2025FullAccounts · bulk data Jul 2025
Derived from the latest filing

How the business works

Profit margin
−20%
Profit ÷ revenue.
Gross margin
74.5%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£61.1k
Revenue ÷ average employees.
Profit per employee
−£12.2k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
2%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
11.2%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£5.9m
Cash at bank
▲113%
Now £335k
Headcount
▼2%
Now 542
Deferred income
—
Now —
Fixed assets
▼54%
Now £666k
Corporate ownership

Group structure

Ownership chain

  1. Eurofins Scientific S.E. (registered outside the UK register)ultimate parent75–100%
  2. Orchid Cellmark Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (1)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2024 (profit −£6.6m), from the Companies House accounts bulk data published Jul 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.